Well, we are a bit off topic here so I won't go on too long but its interesting how having 4 long term (assumed) very high priced contracts (Nurse, Bouchard, Mc-D, Drai) doesn't take too long before it has a profound impact on the rest of the lineup. Without a significant cap increase it becomes even more profound. This is not to say that there won't be significant cap increases but again, revenue projections are just that and nothing more.
If Bouchard wants $11M then that might be his exit point.